Cortisone, an active compound of cortisol, helps in pain-relief and inflammation relief during cases of injury to the joints and arthritis.
Market Analysis and Insights: Global Cortisone Market
Due to the COVID-19 pandemic, the global Cortisone market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Oral Drugs accounting for % of the Cortisone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Cortisone market size is valued at US$ million in 2021, while the US and Europe Cortisone are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cortisone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Cortisone include Merck, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cortisone Scope and Segment
Cortisone market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cortisone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral Drugs
Injectable Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Company
Merck
Novartis
Pfizer
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E